Expanding diagnostic testing for drug-resistant tuberculosis in high burden settings
A cost-effectiveness analysis
Bibliographic Data
| ID | 15371925 |
|---|---|
| Authors | Marya Getchell (0000-0002-5831-4008, SingHealth, corresponding author), John Pastor Ansah (0000-0001-9157-4218, Case Western Reserve University), Dodge R Lim (0000-0002-6271-3861, Department of Health), Dodge Lim, Ramon Basilio (Department of Health), Francis A Tablizo (0009-0007-1392-3671, University of the Philippines System), Francis Tablizo, Carmen Corpuz (Department of Health), David B Matchar (0000-0003-3020-2108, SingHealth), David Matchar |
| Year | 2025 |
| Volume | 25 |
| Issue | 1 |
| Pages | 3795-3795 |
| Publication date | 2025-11-05 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMC Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1471-2458 • E-ISSN: 1471-2458 |
| Publisher | BioMed Central (PUBLISHER • GB) |
| DOI | 10.1186/s12889-025-24934-z |
| PMID | 41194030 |
| OpenAlex | W4415917179 |
| Language | EN |
| References cited | 20 |
In high TB-burden countries, GeneXpert XDR is cost-effective as an additional DR-TB diagnostic test. tNGS is not cost-effective for routine clinical DR-TB testing but has potential for application to high-risk populations, especially with introduction of new TB treatment regimens
Biostatistics · Diagnostic test · GeneXpert MTB/RIF · Public health · Tuberculosis · Tuberculosis diagnosis · Diagnosis and treatment of tuberculosis · HIV/AIDS drug development and treatment · Tuberculosis Research and Epidemiology · Epidemiology
| Citation velocity | historical |
|---|---|
| Highly cited | No |